Cluster Randomized Controlled Screening Trial for NPC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This study is aimed to estimate the effectiveness of an Epstein-Barr virus (EBV) serology-based screening program to reduce nasopharyngeal carcinoma (NPC) mortality in a cluster randomized controlled trial in an NPC high-risk population. Sixteen towns in Sihui and Zhongshan Cities, China will be selected, with eight allocated to the screening group and eight to the control group. Cantonese residents aged 30-69 years with no history of NPC will be included. Residents in the screening towns will be invited to undergo serum EBV VCA/EBNA1 IgA antibody tests.
Epistemonikos ID: 9d65c7b7a975e0046863fc8048263c1168e19f4a
First added on: May 05, 2024